CHAPTER 7 REFERENCES 247shodhganga.inflibnet.ac.in/bitstream/10603/12396/10/13... · 2015. 12. 4. · periodontal diseases. Autoimmun Rev. 10(7), ... herbal formulation for preventing

CHAPTER 7 REFERENCES 247

DEPARTMENT OF PHARMACEUTICS JAMIA HAMDARD

Abdelwahab, S.I., Hassan, L.E., Sirat, H.M., Yagi, S.M., Koko, W.S., Mohan, S., Taha, M.M., Ahmad, S., Chuen, C.S., Narrima, P., Rais, M.M., Hadi, A.H., 2011. Anti-inflammatory activities of cucurbitacin E isolated from Citrullus lanatus var. citroides: Role of reactive nitrogen species and cyclooxygenase enzyme inhibition. Fitoterapia 82(8), 1190-1197.

Abrams, D.A., Robin, A.L., Pollack, I.P., deFaller, J.M., DeSantis, L., 1987. The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers. Arch Ophthalmol. 105(9), 1205-1207.

Addy, M., Langeroudi, M., 1984. Comparison of the immediate effects on the sub-gingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline. J. Clin. Periodontol. 11, 379-386.

Addy, M., Langeroudi, M., Hassan, H., 1985. The development and clinical use of acrylic strips containing antimicrobial agents in the management of chronic periodontitis. Int. Dent. J. 35, 124-131.

Agarwal, R.K., Robinson, D.H., Maze, G.I., Reinhardt, R.A., 1993. Development and characterization of tetracycline-poly(lactide/glycolide) films for treatment of periodontitis. J. Control. Release 23, 137-146.

Aggarwal, B.B., Van Kuiken, M.E., Iyer, L.H., Harikumar, K.B., Sung, B., 2009. Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med. (Maywood) 234, 825-849.

Ahmed, M.G., Harish, N.M., Charyulu, R.N., Prabhu, P., 2009. Formulation of chitosan-based ciprofloxacin and diclofenac film for periodontitis therapy. Trop. J. Pharm. Res. 8, 33-41.

Ahuja, A., Ali, J., Rahman, S., 2006a. Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterization. Pharmazie 61, 25-29.

Ahuja, A., Ali, J., Shareef, A., Khar, R.K. 2006b. Formulation and development of targeted retensive device for the treatment of periodontal infections with amoxycillin trihydrate. Indian J. Pharm. Sci. 68, 442-447.

Aigner, Z., Heinrich, R., Sipos, E., Farkas, G., Ciurba, A., Berkesi, O., Szabó-Révész, P., 2011. Compatibility studies of aceclofenac with retard tablet excipients by means of thermal and FT-IR spectroscopic methods. J. Therm. Anal. Calorim. 104, 265–271.

Ajazuddin, Saraf .S., 2010. Applications of novel drug delivery system for herbal formulations. Fitoterapia 81(7), 680-689.

Akncbay, H., Senel, S., Ay, Z.Y., 2007. Application of chitosan gel in the treatment of chronic periodontitis. J. Biomed. Mater. Res. B Appl. Biomater. 80, 290-296.



Alexis, F., Basto, P., Levy-Nissenbaum, E., Radovic-Moreno, A.F., Zhang, L., Pridgen, E., Wang, A.Z., Marein, S.L., Westerhof, K., Molnar, L.K., Farokhzad, O.C., 2008. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem. 3(12),1839-1843.

Ali, J., Pramod, K., Tahir, M.A., Ansari, S.H., 2011. Autoimmune responses in periodontal diseases. Autoimmun Rev. 10(7), 426-431.

Allaker, R.P., 2010. The use of nanoparticles to control oral biofilm formation. J. Dent. Res. 89, 1175-1186.

Alle´mann, E., Gurny, R., Doelker, E., 1993. Drug-loaded nanoparticles- preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39, 173–191.

Anonymous, 2008. Eugenol prescription acne gel design and preliminary quality assessment. Available from: http://eng.hi138.com/?i134609#. [Accessed 12 April 2009].

Anonymous, 2011. Methods of Analysis. Available from: http://apps.who.int/phint/en/d/Jb/7.1.3.1.html [Accessed 14 August, 2011].

Anonymous, n.d. Herbal remedies for periodontal disease. Available from: http://www.altmd.com/ Articles/Herbal-Remedies-for-Periodontal-Disease [Accessed 31 March, 2009].

Aoshima, H., Hamamoto, K., 1999. Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci. Biotechnol. Biochem. 63, 743-748.

Arangoa, M.A., Campanero, M.A., Renedo, M.J., Ponchel, G., Irache, J.M., 2001. Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm. Res. 18, 1521-1527.

Arellano, A., Santoyo, S., Martin, C., Ygartua, P., 1996. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm. 130, 141-145.

Arica, Y.B., Benoit, J.P., Lamprecht, A., 2006. Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification. Drug Dev. Ind. Pharm. 32, 1089–1094.

Armelin, E., Marti, M., Rude, E., Labanda, J., Llorens, J., Aleman, C., 2006. A simple model to describe the thixotropic behavior of paints. Progr. Org. Coating 57, 229–235.

Armitage, G.C., 2004. Periodontal diagnoses and classification of periodontal diseases. Periodontol. 2000 34, 9-21.

Arora, P., Mukherjee, B., 2002. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 91(9), 2076-2089.



Aruna, D.R., Hemalata, M., 2010. Periodontal regeneration: An appraisal. International Journal of Contemporary Dentistry 1(12), 20-24.

Audebrand, M., Kolb, M., Axelos, M.A., 2006. Combined rheological and ultrasonic study of alginate and pectin gels near the sol-gel transition. Biomacromolecules 7(10), 2811-2817.

Auh, J., Han, C., Shin, Y., Moon, H., Lee, J., Yi, T., Lee, K., Leem, K., 2011. Preventing or treating periodontal diseases by herbal extract. WIPO Patent Application WO2011046395A2.

Awasthi, P.K., Dixit, S.C., Dixit, N., Sinha, A.K., 2008. Eugenol derivatives as future potential drugs. Journal of Pharmacy Research 1, 215-220.

Baker, R.W., Krisko, E.A., Kochinke, F., Grass, M., Armitage, G., Robertson, P., 1988. A controlled release drug delivery system for the periodontal pocket, Proc. Int. Sym. Control. Release Bioactive Materials 140, 238a–238b.

Bakó, J., Szepesi, M., Márton, I., Borbély, J., Hegedûs, C., 2007. Synthesis of nanoparticles for dental drug delivery systems. Fogorv. Sz. 100, 109-113.

Bali, V., Ali, M., Ali, J., 2010. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. J. Drug Target. 18, 506-519.

Barnes, H.A., 1997. Thixotropy - a review. J. Non-Newtonian Fluid Mech. 70, 1-33.

Barnes, J., Anderson, L.A., Phillipson, J.D., 2007. Herbal medicines, third ed. Pharmaceutical Press, London.

Barry, B.W., Meyer, M.C., 1979a. The rheological properties of carbopol gels I. Continuous shear and creep properties of carbopol gels. Int. J. Pharm. 2, 1-25.

Barry, B.W., Meyer, M.C., 1979b. The rheological properties of carbopol gels II. Oscillatory properties of carbopol gels. Int. J. Pharm. 2, 27-40.

Barzaghi, N., Crema, F., Gatti, G., Pifferi, G., Perucca, E., 1990. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. Eur. J. Drug Metab. Pharmacokinet. 15(4), 333-338.

Basu, A., Hoffman, K., 2002. Treatment for inflammatory bowel disease (IBD) and related conditions. US Patent Application US20020025348A1.

Baudez, J.C., 2006. About peak and loop in sludge rheograms. J. Environ. Manage. 78, 232-239.

Behl, H.M., Sidhu, O.P., Pushpangadan, P., Singh, S.C., 2004. Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis. WIPO Patent Application WO2004084852.



Benencia, F., Courrèges, M.C., 2000. In vitro and in vivo activity of eugenol on human herpesvirus. Phytother. Res. 14, 495–500.

Bhumkar, D.R., Pokharkar, V.B., 2006. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech. 7(2), E1-E6.

Bird, R.B., Dai, G.C., Yarusso, B.J., 1982. The rheology and flow of viscoplastic materials. Rev. Chem. Eng. 1, 1-70.

Bollen, C.M., Quirynen, M., 1996. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. J. Periodontol. 67, 1143-1158

Bosnjakovic, A., Mishra, M.K., Ren, W., Kurtoglu, Y.E., Shi, T., Fan, D., Kannan, R.M., 2011. Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation. Nanomedicine 7(3), 284-294.

Botelho, M.A., Martins, J.G., Ruela, R.S., Queiroz, D.B., Ruela, W.S., 2010. Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules. J. Appl. Oral Sci. 18(4), 335-342.

Brigger, I., Dubernet, C., Couvreur, P., 2002. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54, 631–651.

Bromberg, L.E., Braman, V.M., Rothstein, D.M., Spacciapoli, P., O'Connor, S.M., Nelson, E.J., Buxton, D.K., Tonetti, M.S., Friden, P.M., 2000. Sustained release of silver from periodontal wafer for treatment of periodontitis. J. Control. Release 68, 63-72.

Bromberg, L.E., Buxton, D.K., Friden, P.M., 2001. Novel periodontal drug delivery system for treatment of periodontitis. J. Control. Release 71, 251-259.

Bruschi, M.L., Jones, D.S., Panzeri, H., Gremiao, M.P., de Freitas, O., Lara, E.H., 2007. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J. Pharm. Sci. 96, 2074-2089.

Budavari, S., 1989. The merck index: An encyclopedia of chemical, drugs, and biologicals. Merck and Co., Inc., New Jersey.

Burgess, D.J., Hickey, A.J., 2007. Microsphere Technology and Applications, in: Swarbrick, J. (Ed.), Encyclopedia of Pharmaceutical Technology, 3rd ed., Informa Healthcare, New York, pp. 2328-2336.

Burt, S.A., Reinders, R.D., 2003. Antibacterial activity of selected plant essential oils against Escherichia coli O157:H7. Lett. Appl. Microbiol. 36, 162–167.



Cai L, Wu CD. Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens. J Nat Prod 1996; 59 (10): 987-990.

Cai, L., Wei, G.X., Bijl, P.V.D., Wu, C.D., 2000. Namibian chewing stick, Diospyros lycioides, contains antibacterial compounds against oral pathogens. J. Agric. Food Chem. 48(3), 909-914.

Caine, Y., 2008. Herbal periodontal patch (thpp) for gingival inflammation in diabetics. Available from: http://clinicaltrials.gov/ct2/show/study/NCT00731432?view= results [Accessed 01 October, 2011].

Calvo, P., Remunan-Lopez, C., Vila-Jato, J.L., Alonso, M.J., 1997. Novel hydrophilic chitosan polyethylene oxide nanoparticles as protein carriers. J. Applied Polym. Sci., 63, 125-132.

Campaniello, D., Corbo, M.R., Sinigaglia, M., 2010. Antifungal activity of eugenol against Penicillium, Aspergillus, and Fusarium species. J. Food Prot. 73, 1124-1128.

Cao, C.F., Sun, X.P., 1998. Herbal medicine for periodontal diseases. Int. Dent. J. 48(3), 316-322.

Capasso, R., Pinto, L., Vuotto, M.L., Di Carlo, G., 2000. Preventive effect of eugenol on PAF- and ethanol-induced gastric mucosal damage. Fitoterapia 71, S131–S137.

Carmichael, N.M., Dostrovsky, J.O., Charlton, M.P., 2010. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain 149(2), 316-324.

Celli, J.P., Turner, B.S., Afdhal, N.H., Ewoldt, R.H., McKinley, G.H., Bansil, R., Erramilli, S., 2007. Rheology of gastric mucin exhibits a pH-dependent sol-gel transition. Biomacromolecules 8(5),1580-1586.

Chaar, J.S., Mouchreck-Filho, V.E., Breviglieri, S.T., Cavalheiro, É.T.G., Chierice, G.O., 2007. Boiling temperatures and enthalpy changes of essential oils. J. Therm. Anal. Calorim. 75(2), 437-443.

Chacko, A.M., Hood, E.D., Zern, B.J., Muzykantov, V.R., 2011. Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation. Curr. Opin. Colloid Interface Sci. 16(3), 215-227.

Chaieb, K., Hajlaoui, H., Zmantar, T., Kahla-Nakbi, A.B., Rouabhia, M., Mahdouani, K., Bakhrouf, A., 2007. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother. Res. 21, 501-506.

Chainy, G.B.N., Manna, S.K., Chaturvedi, M.M., Aggarwal, B.B., 2000. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 19, 2943–2950.



Chakravarthy, K.V., Davidson, B.A., Helinski, J.D., Ding, H., Law, W.C., Yong, K.T., Prasad, P.N., Knight, P.R., 2011. Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation. Nanomedicine 7(1), 88-96.

Chami, F., Chami, N., Bennis, S., Trouillas, J., Remmal, A., 2004b. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J. Antimicrob. Chemother. 54, 909-914.

Chami, N., Bennis, S., Chami, F., Aboussekhra, A., Remmal, A., 2005. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol. Immunol. 20, 106-111.

Chami, N., Chami, F., Bennis, S., Trouillas, J., Remmal, A., 2004a. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz. J. Infect. Dis. 8, 217-226.

Champagne, C.M., Buchanan, W., Reddy, M.S., Preisser, J.S., Beck, J.D., 2003. Offenbacher S. Potential for gingival crevice fluid markers as predictors of risk for periodontal diseases. Periodontol. 2000 31, 167– 180.

Chan, Y., Lai, C.H., Yang, H.W., Lin, Y.Y., Chan, C.H., 2003. The evaluation of Chinese herbal medicine effectiveness on periodontal pathogens. Am. J. Chin. Med. 31(5), 751-761.

Chanchal, D., Swarnlata, S.. 2008. Novel approaches in herbal cosmetics. J. Cosmet. Dermatol. 7, 89–95.

Chang, R.K., Price, J.C., Whitworth, C.W., 1986. Dissolution characteristics of poly (ε-carolactone)-polylactide microspheres of chlorpromazine. Drug Dev. Ind. Pharm. 12, 2355-2380.

Chaudhary, H., Kohli, K., Amin, S., Rathee, P., Kumar, V., 2010. Optimization And Formulation Design of Gels of Diclofenac and Curcumin for Transdermal Drug Delivery By Box-Behnken Statistical Design. J. Pharm. Sci. 10, 1-14.

Chauhan, V., Suthar, A., Sapre, D., Bal-Tembe, S., gangopadhyay, A., Kulkarni-Almeida, A., Parikh, S., 2007. Herbal composition for inflammatory disorders. WIPO Patent Application WO2007036900.

Chawla, J.S., Amiji, M.M., 2002. Biodegradable poly(ε-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. Int. J. Pharm. 249, 127-138.

Chen, B.J., 2001. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk. Lymphoma 42(3), 253-265.



Chen, F., Shi, Z., Neoh, K.G., Kang, E.T., 2009. Antioxidant and antibacterial activities of eugenol and carvacrol-grafted chitosan nanoparticles. Biotechnol. Bioeng. 104(1), 30-39.

Chen, F.M., Wei, M.A., Dong, G., Wu, Z., 2009. Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery. Acta Pharmacol. Sin. 30(4), 485-493.

Chen, F.M., Zhao, Y.M., Zhang, R., Jin, T., Sun, H.H., Wu, Z.F., Jin, Y., 2007. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J. Control. Release 121, 81-90.

Chen, R., Chiba, M., Mori, S., Fukumoto, M., Kodama, T., 2009. Periodontal gene transfer by ultrasound and nano/microbubbles. J. Dent. Res. 88(11), 1008-1013.

Chen, S., 2005. Botanical extract compositions and methods of use. US Patent Application US20050032882A1.

Chi, S.C., Jun, H.W., 1990. Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats. J. Pharm. Sci. 79(11), 974-977.

Chiappetta, D.A., Degrossi, J., Teves, S., D'Aquino, M., Bregni, C., Sosnik, A., 2008. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm. Eur. J. Pharm. and Biopharm. 69, 535-545.

Cho, J.S., Kim, T.H., Lim, J.M., Song, J.H., 2008. Effects of eugenol on Na(+) currents in rat dorsal root ganglion neurons. Brain Res. 1243, 53-62.

Choudhary, R., Mishra, K.P., Subramanyam, C., 2006. Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidant. Indian J. Clin. Biochem. 21, 107-113.

Chung, G., Rhee, J.N., Jung, S.J., Kim, J.S., Oh, S.B., 2008. Modulation of CaV2.3 calcium channel currents by eugenol. J. Dent. Res. 87, 137-141.

Clove bud oil, 1973. Database of Select Committee on GRAS Substances (SCOGS) Reviews. Available from: http://www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation. cfm?rpt=scogsListing&id=85 [Accessed on 02.10.11].

Cochard, S., Ancey, C., 2009. Experimental investigation of the spreading of viscoplastic fluids on inclined planes. J. Non-Newtonian Fluid Mech. 158, 73–84.

Collins, A.E.M., Deasy, P.B., Maccarthy, D.J., Shanley, D.B., 1989. Evaluation of a controlled-release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodontal disease. Int. J. Pharm. 51, 103-114.



Costa, P., Manuel, J., 2001. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13, 123-133.

Coventry, J., Newman, H.N., 1982. Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation. J. Clin. Periodontol. 9, 129-133.

Crich, A., 1932. Blastomycosis of the gingiva and jaw. Can. Med. Assoc. J. 26(6), 662-665.

Criddle, D.N., Madeira, S.V., De Moura, R.S., 2003. Endothelium-dependent and -independent vasodilator effects of eugenol in the rat mesenteric vascular bed. J. Pharm. Pharmacol. 55, 359-365.

D’Acquisto, F., Iuvone, T., Rombola, L., Sautebin, L., Di Rosa, M., Carnuccio, R., 1997. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett. 418, 175–178.

D’Cruz, O.J., Uckun, F.M., 2006. Influence of long-term stability conditions on microbicidal nucleoside prodrug (WHI-07)-loaded gel-microemulsion. AAPS PharmSciTech. 7 (3), E1-E8.

Damiani, C.E., Moreira, C.M., Zhang, H.T., Creazzo, T.L., Vassallo, D.V., 2004. Effects of eugenol, an essential oil, on the mechanical and electrical activities of cardiac muscle. J. Cardiovasc. Pharmacol. 44, 688-695.

Damiani, C.E.N., Rossoni, L.V., Vassallo, D.V., 2003. Vasorelaxant effects of eugenol on rat thoracic aorta. Vasc. Pharmacol. 40, 59-66.

Deasy, P.B., Collins, A.E.M., Maccarthy, D.J., Russell, R.J., 1989. Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease. J. Pharm. Pharmacol. 41, 694-699.

Devarajan, V., Ravichandran, V., 2011. Nanoemulsions: as modified drug delivery tool. Pharmacie Globale (IJCP) 4, 1-6.

Dighe, V.V., Gursale, A.A., Sane, R.T., Menon, S., Patel, P.H., 2005. Quantitative determination of eugenol from Cinnamomum tamala Nees and Eberm. leaf powder and polyherbal formulation using reverse phase liquid chromatography. Chromatographia. 61, 443–446.

Domb, A.J., Wolnerman, J.S., 2003. Absorbable solid compositions for topical treatment of oral mucosal disorders. US Patent Application US20030003140A1.

Draelos, Z.D., Carter, E., Maloney, J.M., Elewski, B., Poulin, Y., Lynde, C., Garrett, S., 2007. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J. Am. Acad. Dermatol. 56(3), 439.e1-439.e 10.



Drisko, C.H., 1996. Non-surgical pocket therapy, pharmacotherapeutics. Ann. Periodontol. 1, 491-566.

Drulis-Kawa, Z., Dorotkiewicz-Jach, A., 2010. Liposomes as delivery systems for antibiotics. Int. J. Pharm. 387(1-2), 187-198.

Duarte, P.M., Tezolin, K.R., Figueiredo, L.C., Feres, M., Bastos, M.F., 2010. Microbial profile of ligature-induced periodontitis in rats. Arch. Oral Biol. 55(2), 142-147.

Dulin, J.M., 2006. Oral Hygiene System and Method of Treatment. US Patent Application US20060257331A1.

Dung, T.H., Lee, S.R., Han, S.D., Kim, S.J., Ju, Y.M., Kim, M.S., Yoo, H., 2007. Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment. J. Nanosci. Nanotechnol. 7, 3695-3699.

Elena, V.B., Tatiana, K.B., Joseph, A.V., Alexander, V.K., 2006. Polymer Micelles as Drug Carriers, in: Vladimir, P.T. (Ed.), Nanoparticulates as Drug Carriers. Imperial college press, London, pp. 57-81.

El-Kamel, A.H., Ashri, L.Y., Alsarra, I.A., 2007. Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS PharmSciTech. 8(3), E1-E11.

Elkayam, R., Friedman, M., Stabholz, A., Soskolne, A.W., Sela, M.N., Golub, L., 1988. Sustained release device containing minocycline for local treatment of periodontal disease. J. Control. Release 7, 231-236.

El-Zemity, S.R., Radwan, M.A., Mohamed, S.A.E., Sherby, S.M., 2008. Antibacterial screening of some essential oils, monoterpenoids and novel N-methyl carbamates based on monoterpenoids against Agrobacterium tumefaciens and Erwinia carotovora. Arch. Phytopathology Plant Protect. 41, 451-461.

Eperon, S., Bossy-Nobs, L., Petropoulos, I.K., Gurny, R., Guex-Crosier, Y., 2008. A biodegradable drug delivery system for the treatment of postoperative inflammation. Int. J. Pharm. 352(1-2), 240-247.

Esposito, P., Carotta, V., Scabbia, A., Trombelli, L., D'Antona, P., Menegatti, E., Nastruzzi, C., 1996. Comparative analysis of tetracycline containing dental gels: poloxamer- and monoglyceride-based formulations. Int. J. Pharm. 142, 9-23.

Esposito, P., Cortesi, R., Cervellati, F., Menegatti, E., Nastruzzi, C., 1997. Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: formulatory and drug release studies. J. Microencapsul. 14, 175-187.

Fang, J.Y., Fang, C.L., Liu, C.H., Su, Y.H., 2008. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 70(2), 633-640.



FDA Guidance for Industry, 1997. Dissolution testing of immediate and modified release of solid oral dosage forms. National Press Office, Rockville.

Ferranti, V., Marchais, H., Chabenat, C., Orecchioni, A.M., Lafont, O., 1999. Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. Int. J. Pharm. 193, 107–111.

Ferrero-Miliani, L., Nielsen, O.H., Andersen, P.S., Girardin, S.E., 2007. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol. 147, 227–235.

Fiedler-Weiss, V.C., 1987. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J. Am. Acad. Dermatol. 16(3 Pt 2), 745-748.

Fine, D.H., Pechersky, J.L., McKibben, D.H., 1969. The penetration of human gingival sulcular tissue by carbon particles. Arch. Oral Biol. 14, 1117–1119.

Fischer, I.U., Unruh, G.E.V., Dengler, H.J., 1990. The metabolism of eugenol in man. Xenobiotica 20, 209-222.

Franck, A., 2005. Creep recovery measurements of polymers. 77th Annual meeting of the American society of Rheology, Vancouver, British Columbia.

Franklin, A.G., Krizek, R.J., 1969. Complex viscosity of a kaolin clay. Clays and Clay Minerals 17, 101-110.

Freireich, E.J., Gehan, E.A., Rall, D.P., Schmidt, L.H., Skipper, H.E., 1996. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50, 219-244.

Freitas Jr, R.A., 2000. Nanodentistry. J. Am. Dent. Assoc. 131, 1559-1565.

Friedman, M., Golomb, G., 1982. New sustained release dosage form of chlorhexidine for dental use. J. Periodontal. Res. 17, 323-328.

Friedman, M., Kozukue, N., Harden, L.A., 2000. Cinnamaldehyde content in foods determined by gas chromatography-mass spectrometry. J. Agric. Food Chem. 48(11), 5702-5709.

Fujisawa, S., Atsumi, T., Kadoma, Y., Sakagami, H., 2002. Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 177, 39-54.

Fujisawa, S., Masuhara, E., 1981. Binding of eugenol and o-ethoxybenzoic acid to bovine serum albumin. J. Dent. Res. 60, 860-864.

Gad, H.A., El-Nabarawi, M.A., Abd El-Hady, S.S., 2008. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS PharmSciTech 9, 878-884.



Gardiner, J., Freeman, S., Leach, M., Green, A., Alcock, J., D'Emanuele, A., 2008. PAMAM dendrimers for the delivery of the antibacterial Triclosan. J. Enzyme Inhibit. Med. Chem. 23, 623-628.

Garg, A., Singh, S., 2011. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids Surf. B Biointerfaces 87(2), 280-288.

Gelperina, S., Kisich, K., Iseman, M.D., Heifets, L., 2005. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med. 172(12),1487-1490.

Ghaffar, O., Hamid, Q., Renzi, P.M., Allakhverdi, Z., Molet, S., Hogg, J.C., Shore, S.A., Luster, A.D., Lamkhioued, B., 1999. Constitutive and cytokine stimulated expression of eotaxin by human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 159, 1933–1942.

Ghosh, M.N., 2005. Fundamentals of Experimental Pharmacology, third ed. Hilton and company publishers, Kolkata.

Goffin, G., 1998. Efficacy of sustained local delivery of chlorhexidine Periochip as an adjuvant to scaling and root planning in the treatment of chronic periodontal disease. Int. Dent. Rev. 18, 1-18.

Golomb, G., Friedman, M., Soskolne, A., Stabholz, A., Sela, M.N., 1984. Sustained release device containing metronidazole for periodontal use. J. Dent. Res. 63, 1149-1153.

Gomes, C., Moreira, R.G., Castell-Perez, E., 2011. Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications. J. Food Sci.76(2), N16-N24.

Goodson, J.M., Haffajee, A., Socransky, S.S., 1979. Periodontal therapy by local delivery of tetracycline. J. Clin. Periodontol. 6, 83-92.

Gorav, S., Kamlesh, V., Nidhi, P., 2010. Nanodentistry-The future ahead. Baba Farid University Dental Journal 1(1), 43-45.

Greve, H., Greve, R., 2005. Composition for the treatment of dental and periodontal diseases. US20050106113A1.

Guenette, S.A., Beaudry, F., Marier, J.F., Vachon, P., 2006. Pharmacokinetics and anesthetic activity of eugenol in male Sprague–Dawley rats. J. Vet. Pharmacol. Therapeut. 29, 265-270.

Guenette, S.A., Ross, A., Marier, J.F., Beaudry, F., Vachon, P., 2007. Pharmacokinetics of eugenol and its effects on thermal hypersensitivity in rats. Eur. J. Pharmacol. 562, 60-67.



Guibaud, G., Tixier, N., Baudu, M., 2005. Hysteresis area, a rheological parameter used as a tool to assess the ability of filamentous sludges to settle. Process Biochem. 40, 2671–2676.

Guinesi, L.S., Cavalheiro, E.T.G., 2006. The use of DSC curves to determine the acetylation degree of chitin/chitosan samples. Thermochim. Acta 444, 128–133.

Gümüş, G., n.d. Periodontal disease. Available from: http://turker_a.web.ibu.edu.tr/ bio319/Gunduz/Periodontal%20diseases.ppt [Accessed on 31 March, 2009].

Guo, D., Xu, L., Cao, X., Guo, Y., Ye, Y., Chan, C.O., Mok, D.K., Yu, Z., Chen, S., 2011. Anti-inflammatory activities and mechanisms of action of the petroleum ether fraction of Rosa multiflora Thunb. hips. J. Ethnopharmacol. (In Press).

Guo, J.H., 2003. Carbopol® polymers for pharmaceutical drug delivery applications. Drug development and delivery. 3(6). Available from: http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=4&id=C691909D749749438ABEF792F1A24A69 [Accessed 21 May, 2010].

Gupta, G.D., Gaud, R.S., 2006. Antiinflammatory activity of tenoxicam gel on carrageenan-induced paw oedema in rats. Indian J. Pharm. Sci. 68, 356-359.

Gupta, H., Sharma, A., Shrivastava, B., 2009. Pluronic and chitosan based in situ gel system for periodontal application. Asian J. Pharm. 3, 94-96.

Hammer, K.A., Carson, C.F., Riley, T.V., 1999. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol. 86(6), 985-990.

Hamrapurkar, P., Patil, P., Phale, M., Gandhi, M., Pawar, S., 2011. A developed and validated stability-indicating reverse-phase high performance liquid chromatographic method for determination of cefdinir in the presence of its degradation products as per International Conference on Harmonization guidelines. Pharm. Methods 2, 15-20.

Harvey, C.E., Emily, P.P., 1993. Periodontal Disease, in: Harvey, C.E., Emily, P.P. (Eds.), Small Animal Dentistry. Mosby, St. Louis, pp. 89-144.

Hayashi, K., Takada, K., Hirasawa, M., 1998. Clinical and microbiological effects of controlled release local delivery of minocycline on periodontitis in dogs. Am. J. Vet. Res. 59, 464-467.

He, M., Du, M., Fan, M., Bian, Z., 2007. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 163, 137-143.

Hemaiswarya, S., Doble, M., 2009. Synergistic interaction of eugenol with antibiotics against Gram negative bacteria. Phytomedicine 16, 997-1005.



Higashi, K., Matsushita, M., Morisaki, K., Hayashi, S.I., Mayumi, T., 1991. Local drug delivery systems for the treatment of periodontal disease. J Pharmacobiodyn. 14,72-81.

Higashi, K., Morisaki, K., Hayashi, S., Kitamura, M., Fujimoto, N., Kimura, S., Ebisu, S., Okada, H., 1990. Local ofloxacin delivery using a controlled release insert (PT-01) in the human periodontal pocket. J. Periodontal Res. 25, 1-5.

Hillgren, A., Lindgren, J., Aldén, M., 2002. Protection mechanism of Tween 80 during freeze-thawing of a model protein, LDH. Int. J. Pharm. 237(1-2), 57-69.

Hussain, A., Brahmbhatt, K., Priyani, A., Ahmed, M., Rizvi, T.A., Sharma, C., 2011. Eugenol Enhances the Chemotherapeutic Potential of Gemcitabine and Induces Anticarcinogenic and Anti-inflammatory Activity in Human Cervical Cancer Cells. Cancer Biother. Radiopharm. 26(5), 519-527.

Iannitelli, A., Grande, R., Di Stefano, A., Di Giulio, M., Sozio, P., Bessa, L.J., Laserra, S., Paolini, C., Protasi, F., Cellini, L., 2011. Potential antibacterial activity of carvacrol-loaded Poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int. J. Mol. Sci. 12(8), 5039-5051.

ICH Harmonised tripartite guideline, 1996. Stability testing: Photostability testing of new drug substances and products Q1B. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1B/Step4/Q1B_Guideline.pdf [Accessed 10 September, 2011].

ICH Harmonised tripartite guideline, 2003. Stability Testing of New Drug Substances and Products Q1A(R2). Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf [Accessed 10 September, 2011].

ICH Harmonised tripartite guideline, 2005. Validation of analytical procedures: Text and methodology Q2(R1). Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf [Accessed 10 September, 2011].

Inapagolla, R., Guru, B.R., Kurtoglu, Y.E., Gao, X., Lieh-Lai, M., Bassett, D.J., Kannan, R.M., 2010. In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation. Int. J. Pharm. 399(1-2), 140-147.

Integrated publishing, n.d. Clinical uses of zinc oxide and eugenol. Available from: http://www.tpub.com/content/armymedical/MD0502/MD05020025.htm) [Accessed 20 August, 2011].

Interaminense, L.F., Jucá, D.M., Magalhães, P.J., Leal-Cardoso, J.H., Duarte, G.P., Lahlou, S., 2007. Pharmacological evidence of calcium-channel blockade by essential oil of Ocimum gratissimum and its main constituent, eugenol, in isolated aortic rings from DOCA-salt hypertensive rats. Fundam. Clin. Pharmacol. 21, 497-506.



IP, 2007. The Indian Pharmacopoeia Commission. Ghaziabad, India.

Islam, M.T., Rodríguez-Hornedo, N., Ciotti, S., Ackermann, C., 2004. Rheological characterization of topical carbomer gels neutralized to different pH. Pharm. Res. 21, 1192-1199.

Jadhav, B.K., Khandelwal, K.R., Ketkar, A.R., Pisal, S.S., 2004. Formulation and evaluation of mucoadhesive nanocapsules containing eugenol for the treatment of periodontal diseases. Drug Dev. Ind. Pharm. 30:195-203.

Jadhav, B.K., Khandelwal, K.R., Ketkar, A.R., Pisal, S.S., 2004. Formulation and evaluation of mucoadhesive tablets containing eugenol for the treatment of periodontal diseases. Drug Dev. Ind. Pharm. 30(2), 195-203.

Jaeghere, F.D., Doelker, E., Gurny, R., 1999. Nanoparticles, in: Mathiowitz, E. (Ed.), Encyclopedia of Controlled Drug Delivery, Vol. 1 & 2, John Wiley & Sons, Inc., Toronto, pp. 641-664.

Jain, N., Jain, G.K., Javed, S., Iqbal, Z., Talegaonkar, S., Ahmad, F.J., Khar, R.K., 2008. Recent approaches for the treatment of periodontitis. Drug Discov. Today 13, 932-943.

Jeyanthi, R., Akiyama, A., Roberts, F.D., Van Hamont, J., Friden, P., 1997. One-month controlled release of an antimicrobial peptide from biodegradable poly(lactide/glycolide) microspheres for the treatment of periodontitis. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24, 883-884.

Jiao, J., 2008. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv. Drug Deliv. Rev. 60(15), 1663-1673.

Jin, H.L., Wu, W., Shu, R., 2010. Doxycycline nano-liposome slow-release gel improves rat periodontitis. Shanghai Kou Qiang Yi Xue 19(5), 508-511.

Jin, Q.M., Anusaksathien, O., Webb, S.A., Rutherford, R.B., Giannobile, W.V., 2003. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J. Periodontol. 74(2), 202-213.

Jirovetz, L., Buchbauer, G., Stoilova, I., Stoyanova, A., Krastanov, A., Schmidt, E., 2006. Chemical composition and antioxidant properties of clove leaf essential oil. J. Agric. Food Chem. 54, 6303-6307.

Jones, A.A., Kornman, K.S., Newbold, D.A., Manwell, M.A., 1994. Clinical and microbiological effects of controlled release locally delivered minocycline in periodontitis. J. Periodontol. 65(11), 1058-1066.

Jones, D.S., Woolfson, A.D., Brown, A.F., O'Neill, M.J., 1997. Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J. Control. Release 49, 71-79.



Jones, D.S., Woolfson, A.D., Djokic, J., Coulter, W.A., 1996. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res. 13, 1734-1738.

Jones, M.N., Francis, S.E., Hutchinson, F.J., Lyle, I.G., 1993. Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes. Biochim. Biophys. Acta, 1147(2), 251–261.

Jones, M.N., Song, Y.H., Kaszuba, M., Reboiras, M.D., 1997. The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides. J Drug Target. 5(1), 25-34.

Jones, M.N., Kaszuba, M., Reboiras, M.D., Lyle, I.G., Hill, K.J., Song, Y.H., Wilmot, S.W., Creeth, J.E., 1994. The targeting of phospholipid liposomes to bacteria. Biochim. Biophys. Acta. 1196(1), 57–64.

Joshi, M., Patravale, V., 2008. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm. 346(1-2), 124-132.

Jung, B.O., Chung, S.J., Lee, S.B., 2006. Preparation and characterization of eugenol-grafted chitosan hydrogels and their antioxidant activities. J. Appl. Polym. Sci. 99, 3500-3506.

Kabuto, H., Tada, M., Kohno, M., 2007. Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol. Pharmaceut. Bull. 30, 423-427.

Kaldahl, W.B., Kalkwarf, K.L., Patil, K.D., 1993. A review of longitudinal studies that compared periodontal therapies. J. Periodontol. 64, 243-253.

Kamboj, S., Sharma, D., Bala, S., Ansari, S.H., Ali, J., Pramod, K., Nishad, D., Rana, S., Sharma, R.K., 2012. Optimization of disodium edetate topical gel using central composite design and evaluation for external radioactive decontamination. Elixir Pharmacy 42, 6144-6150.

Kaparissides, C., Alexandridou, S., Kotti, K., Chaitidou, S., 2006. Recent Advances in Novel Drug Delivery Systems. Available from: http://www.azonano.com/article.aspx?ArticleID=1538 [Accessed 24 September, 2009].

Kar Mahapatra, S., Chakraborty, S.P., Majumdar, S., Bag, B.G., Roy, S., 2009. Eugenol protects nicotine-induced superoxide mediated oxidative damage in murine peritoneal macrophages in vitro. Eur. J. Pharmacol. 623, 132-140.

Kaur, G., Athar, M., Alam, M.S., 2010. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol. Carcinog. 49, 290-301.



Kayser, O., Lemke, A., Hernández-Trejo, N., 2005. The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol. 6, 3-5.

Khare, C.P., 2007. Indian medicinal plants. Springer-Verlag, Berlin.

Kim, J., Kim, S., Kim, H., Ko, S., Baek, D., 2010. Herbal mixture extract of Pleurotus eryngii, Acanthopanacis Cortex and Notoginseng Radix and a composition comprising the same for prevention and treatment of periodontitis. US Patent Application US20100196288A9.

Kim, J., Kim, S., Kim, S., Ko, S., Baek, D., 2006. A herbal mixture extract of pleurotus eryngii, acanthopanacis cortex and notoginseng radix and a composition comprising the same for prevention and treatment of periodontitis. WO2006088324.

Kishore, R.S., Pappenberger, A., Dauphin, I.B., Ross, A., Buergi, B., Staempfli, A., Mahler, H.C., 2011. Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis. J. Pharm. Sci. 100(2), 721-731.

Kittur, F.S., Prashanth, K.V.H., Sankar, K.U., Tharanathan, R.N., 2002. Characterization of chitin, chitosan and their carboxymethyl derivatives by differential scanning calorimetry. Carbohydr. Polym. 49(2), 185-193.

Koch, P.S., 1999. Efficacy of lidocaine 2% jelly as a topical agent in cataract surgery. J. Cataract Refract. Surg. 25(5), 632-634.

Kolahi, J., 2010. Anti-nanobacterial therapy for prevention and control of periodontal diseases. Dental Hypothesis 1(1), 4-8.

Koleske, J.V., 1978. Blends containing poly(ε-caprolactone) and related polymers, in: Paul, D.R., Newman, S. (Eds.), Polymer Blends, vol. 2. Academic Press, New York, pp. 369-389.

Kong, L.X., Peng, Z., Li, S.D., Bartold, P.M., 2006. Nanotechnology and its role in the management of periodontal diseases. Periodontol. 2000 40, 184-196.

Kopleman, S.H., Augsburger, L.L., NguyenPho, A., Zito, W.S., Muller, F.X., 2001. Selected physical and chemical properties of commercial hypericum perforatum extracts relevant for formulated product quality and performance. AAPS PharmSci. 3(4), 1–18.

Kornman, K.S., 1993. Controlled release local delivery antimicrobials in periodontics. Prospects for the future. J. Periodontol. 64, 782-791.

Kreuter, J., 1994. Nanoparticles, in: Kreuter, J. (Ed.), Colloidal Drug Delivery Systems. Marcel Dekker, New York, pp. 219-315.

Kreuter, J., 2004. Nanoparticles as drug delivery system, in: Nalwa, H.S. (Ed.), Encyclopedia of nanoscience and nanotechnology. Vol. 7. American Scientific Publishers, New York, pp. 161-180.



Kriegel, C., Kit, K.M., McClements, D. J., Weiss, J., 2010. Nanofibers as carrier systems for antimicrobial microemulsions. II. Release characteristics and antimicrobial activity. J. Appl. Polym. Sci. 118, 2859–2868.

Krishna, G., Hodnick, W.F., Lang, W., Lin, X., Karra, S., Mao, J., Almassian, B., 2001. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M. AAPS PharmsciTech. 2 (3), 1-9.

Kubik, T., Bogunia-Kubik, K., Sugisaka, M., 2005. Nanotechnology on duty in medical applications. Curr. Pharm. Biotechnol. 6(1), 17 - 33.

Kumaravelu, P., Dakshinamoorthy, D.P., Subramaniam, S., Devaraj, H., Devaraj, N.S., 1995. Effect of eugenol on drug-metabolizing enzymes of carbon tetrachloride-intoxicated rat liver. Biochem. Pharmacol. 49, 1703-1707.

Kurian, R., Arulmozhi, D.K., Veeranjaneyulu, A., Bodhankar, S.L., 2006. Effect of eugenol on animal models of nociception. Indian J. Pharmacol. 38, 341-345.

Kyun, K.D., Yun, K.S., Young, J.S., Pyoung, C.C., Heui, S.S., 1990. Development of minocycline containing polycaprolactone film as a local drug delivery. Taehan Chikkwa Uisa Hyophoe Chi 28, 279-290.

Lapasin, R., Grassi, M., Coceani, N., 2001. Effects of polymer addition on the rheology of o/w microemulsions. Rheol. Acta 40,185-192.

Larsen, T., 1990. In vitro release of doxycycline from bioabsorbable materials and acrylic strips. J. Periodontol. 61, 30-34.

Lawrie, G., Keen, I., Drew, B., Chandler-Temple, A., Rintoul, L., Fredericks, P., Grøndahl, L., 2007. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules 8(8), 2533-2541.

Lee, C.H., Moturi, V., Lee, Y., 2009. Thixotropic property in pharmaceutical formulations. J. Control. Release 136, 88-98.

Lee, M.H., Yeon, K.Y., Park, C.K., Li, H.Y., Fang, Z., Kim, M.S., Choi, S.Y., Lee, S.J., Lee, S., Park, K., Lee, J.H., Kim, J.S., Oh, S.B., 2005. Eugenol inhibits calcium currents in dental afferent neurons. J. Dent. Res. 84, 848-851.

Lee, Y.Y., Hung, S.L., Pai, S.F., Lee, Y.H., Yang, S.F., 2007. Eugenol suppressed the expression of lipopolysaccharide-induced proinflammatory mediators in human macrophages. J. Endod. 33, 698-702.

Leggott, P.J., Robertson, P.B., Rothman, D.L., Murray, P.A., Jacob, R.A., 1986. The effect of controlled ascorbic acid depletion and supplementation on periodontal health. J. Periodontol. 57, 480-485.



Leonard, T.W., Mikula, K.K., Schlesinger, M.S., 1989. Eugenol enhancement of transdermal drug delivery. US Patent 4888362.

Lertsutthiwong, P., Noomun, K., Jongaroonngamsang, N., Rojsitthisak, P., Nimmannit, U., 2008. Preparation of alginate nanocapsules containing turmeric oil. Carbohyd. Polym. 74, 209–214.

Lertsutthiwong, P., Rojsitthisak, P., Nimmannit, U., 2009. Preparation of turmeric oil-loaded chitosan-alginate biopolymeric nanocapsules. Mat. Sci. Eng. C-Bio. S. 29, 856–860.

Levine, W. Z., Saffer, A. J., Faran, M. 2002. Herbal compositions for the treatment of mucosal lesions. WIPO Patent Application WO02094300.

Li, H.Y., Park, C.K., Jung, S.J., Choi, S.Y., Lee, S.J., Park, K., Kim, J.S., Oh, S.B., 2007. Eugenol inhibits K+ currents in trigeminal ganglion neurons. J. Dent. Res. 86, 898-902.

Li, Y., Sun, Z., Zheng, P., 2004. Determination of vanillin, eugenol and isoeugenol by RP-HPLC. Chromatographia 60, 709–713.

Lim, E.K., Yang, J., Suh, J.S., Huh, Y.M., Haam, S., 2009. Self-labeled magneto nanoprobes using tri-aminated polysorbate 80 for detection of human mesenchymal stem cells. J. Mater. Chem. 19, 8958-8963. (Supplementary material. Available from: http://www.rsc.org/suppdata/JM/b9/b912149h/b912149h.pdf [Accessed 23 June, 2011].

Lisa, S., 2009. Natural remedies for treating periodontal disease, http://www.associatedcontent.com/article/791515/natural_remedies_for_treating_periodontal.html?cat=5 [Accessed 10 March, 2009].

Liu, H., Cai, Q., Lian, P., Fang, Z., Duan, S., Ryu, S., Yang, X., Deng, X., 2010. The biological properties of carbon nanofibres decorated with beta-tricalcium phosphate nanoparticles. Carbon 48, 2266-2272.

Lockwood, B., 2007. Neutraceuticals A guide for healthcare professionals, second ed. Pharmaceutical Press, London.

Ma, Q., Kinneer, K., 2002. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J. Biol. Chem. 277, 2477–2484.

Magalhães, C.B., Riva, D.R., DePaula, L.J., Brando-Lima, A., Koatz ,V.L., Leal-Cardoso, J.H., Zin, W.A., Faffe, D.S., 2010. In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J. Appl. Physiol. 108(4), 845-851.

Magyar, J., Szentandrássy, N., Bányász, T., Fülöp, L., Varró, A., Nánási, P.P., 2004. Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes. Eur. J. Pharmacol. 487, 29-36.



Mainardes, R.M., Evangelista, R.C., 2005. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int. J. Pharm. 290,137–144.

Maisch, T., 2007. Anti-microbial photodynamic therapy: useful in the future? Lasers Med. Sci. 22(2), 83-91.

Masae, I.T.O., Keiko, M., Masataka, Y., 2005. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem. Toxicol. 43, 461-466.

Mason, P., 2007. Dietary supplements, third ed. Pharmaceutical Press, London.

Maze, G.I., Reinhardt, R.A., Agarwal, R.K., Dyer, J.K., Robinson, D.H., DuBois, L.M., Tussing, G.J., Maze, C.R., 1995. Response to intracrevicular controlled delivery of 25% tetracycline from poly(lactide:glycolide) film strips in SPT patients. J. Clin. Periodontol. 22, 860-867.

Maze, G.I., Reinhardt, R.A., Payne, J.B., Maze, C., Baker, R.A., Bouwsma, O.J., Damani, N.C., Fitzgerald, J., Hamlin, J.C., Gerlach, R.W., 1996. Gingival fluid tetracycline release from bioerodible gels. J. Clin. Periodontol. 23, 1133-1136.

Medina, O.P., Zhu, Y., Kairemo, K., 2004. Targeted liposomal drug delivery in cancer. Curr. Pharm. Des. 10, 2981–2989.

Medlicott, N.J., Rathbone, M.J., Tucker, I.G., Holborow, D.W., 1994. Delivery systems for the administration of drugs to the periodontal pocket. Adv. Drug Deliv. Rev., 13, 181-203.

Mei, Z., Chen, H., Weng, T., Yang, Y., Yang, X., 2003. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56(2), 189-196.

Merchant, H.A., Shoaib, H.M., Tazeen, J., Yousuf , R., 2006. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech. 7(3), E178–E183.

Mewis, J., Wagner, N.J., 2009. Thixotropy. Adv. Colloid Interface Sci. 147-148, 214-227.

Miller, R.A., Bussell, N.E., Ricketts, C.K., Jordi, H., 1979. Analysis and purification of eugenol. J. Dent. Res. 58(4),1394-1400.

Minabe, M., Takeuchi, K., Tamura, T., Hori, T., Umemoto, T., 1989. Subgingival administration of tetracycline on a collagen film. J. Periodontol. 60, 552-556.

Miyasaki, K.T., Nisengard, R.J., Haake, S.K., 2004. Immunity and inflammation; basic concepts, in: Newman, M.G., Takei, H.H., Carranza, F.A. (Eds.), Carranza’s Clinical Periodontology. ninth ed. W.B. Saunders, Philadelphia, pp. 113– 132.



Miyazawa, M., Hisama, M., 2003. Antimutagenic activity of phenylpropanoids from clove (Syzygium aromaticum). J. Agric. Food Chem. 51, 6413-6422.

Mohammed, M.J., Al-Bayati, F.A.,2009. Isolation and identification of antibacterial compounds from Thymus kotschyanus aerial parts and Dianthus caryophyllus flower buds. Phytomedicine 16(6-7), 632-637.

Moller, P., Fall, A., Chikkadi, V., Derks, D., Bonn, D., 2009. An attempt to categorize yield stress fluid behaviour, Philos. Transact. A Math. Phys. Eng. Sci. 367, 5139-5155.

Molnar, E.J., 1967. Residual eugenol from zinc oxide-eugenol compounds. J. Dent. Res. 46, 645-649.

Mombelli, A., Van Winkelhoff, A.J., 1997. The systemic use of antibiotics in periodontal therapy, in: Lang, N.P., Karring, T., Lindhe, J. (Eds.), Proceedings of the Second European Workshop on Periodontology. Quintessence Publishing, London, pp.38-77.

Monteiro, O.S., Souza, A.G., Soledade, L.E.B., Queiroz, N., Souza, A.L., Mouchrek Filho, V.E., Vasconcelos, A.F.F., 2011. Chemical evaluation and thermal analysis of the essential oil from the fruits of the vegetable species Pimenta dioica Lindl. J. Therm. Anal. Calorim. 106, 595-600.

Moon, H.S., Lee, B.R., Lee, K.H., 2003. Method for preparation of plant extract powder. US Patent Application US20036503541.

Moore, J.W., Flanner, H.H., 1996. Mathematical Comparison of Dissolution Profiles. Pharm. Tech. 20(6), 64-74.

Morsy, M.A., Fouad, A.A., 2008. Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats. Phytother. Res. 22, 1361–1366.

Moulari, B., Lboutounne, H., Chaumont, J.P., Guillaume, Y., Millet, J., Pellequer, Y., 2006. Potentiation of the bactericidal activity of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) leaf extract against oral bacteria using poly (D,L-lactide-co-glycolide) nanoparticles: in vitro study. Acta Odontol. Scand. 64, 153-158.

Muià, C., Mazzon, E., Maiere, D., Zito, D., Di Paola, R., Domenico, S., Crisafulli, C., Britti, D., Cuzzocrea, S., 2006. Pyrrolidine dithiocarbamate reduced experimental periodontitis. Eur. J. Pharmacol. 539(3), 205-210.

Muller-Goymann, C.C., 2004. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur. J. Pharm. Biopharm. 58, 343-356.

Mundargi, R.C., Srirangarajan, S., Agnihotri, S.A., Patil, S.A., Ravindra, S., Setty, S.B., Aminabhavi, T.M., 2007. Development and evaluation of novel biodegradable microspheres based on poly(D,L-lactide-co-glycolide) and poly(epsiloncaprolactone) for



controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J. Control. Release 119, 59-68.

Murakami, Y., Shoji, M., Hanazawa, S., Tanaka, S., Fujisawa, S., 2003. Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor kappaB activation and inflammatory cytokine expression in macrophages. Biochem. Pharmacol. 66, 1061–1066.

Murakami, Y., Shoji, M., Hirata, A., Tanaka, S., Yokoe, I., Fujisawa, S., 2005. Dehydrodiisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide- stimulated nuclear factor kappaB activation and cyclooxygenase-2 expression in macrophages. Arch. Biochem. Biophys. 434, 326–332.

Murthy, R.S.R., 1997. Biodegradable polymers, in: Jain, N.K. (Ed.), Controlled and Novel Drug Delivery. CBS Publisher, New Delhi, pp. 27-51.

Musick, J.R., 2006. Diagnostic test kit and methods of diagnosis and treatment of Helicobacter SPP. associated infections. US Patent Application US20060078919.

Mutalik, S., Udupa, N., 2003. Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin. Pharmazie 58(12), 891-894.

Mutalik, S., Udupa, N., 2005. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide. J. Pharm. Pharm. Sci. 8(1), 26-38.

Muthu, M.S., 2009. Nanoparticles based on PLGA and its co-polymer: An overview. Asian J Pharm. 3, 266-273.

Mytle, N., Anderson, G.L., Doyle, M.P., Smith, M.A., 2006. Antimicrobial activity of clove (Syzgium aromaticum) oil in inhibiting Listeria monocytogenes on chicken frankfurters. Food Control 17, 102–107.

Nafea, E.H., El-Massik, M.A., El-Khordagui, L.K., Marei, M.K., Khalafallah, N.M., 2007. Alendronate PLGA microspheres with high loading efficiency for dental applications. J. Microencapsul. 24(6), 525-538.

Nagababu, E., Lakshmaiah, N., 1994. Inhibition of microsomal lipid peroxidation and monooxygenase activities by eugenol. Free Radic. Res. 20, 253-266.

Nagababu, E., Sesikeran, B., Lakshmaiah, N., 1995. The protective effects of eugenol on carbon tetrachloride induced hepatotoxicity in rats. Free Radic. Res. 23, 617-627.

Nair, H.B., Sung, B., Yadav, V.R., Kannappan, R., Chaturvedi, M.M., Aggarwal, B.B., 2010. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem. Pharmacol. 80(12), 1833-1843.



Napimoga, M.H., Benatti, B.B., Lima, F.O., Alves, P.M., Campos, A.C., Pena-Dos-Santos, D.R., Severino, F.P., Cunha, F.Q., Guimarães, F.S., 2009. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int. Immunopharmacol. 9(2), 216-222.

Natarajan, V., Krithica, N., Madhan, B., Sehgal, P.K., 2011. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. J. Pharm. Sci. 100(1), 195-205.

National library of medicine, 2005. Eugenol. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@DOCNO+210 [Accessed 04 July, 2011].

Needleman, I.G., 1991. Controlled drug release in periodontics. A review of new therapies. Br. Dent. J. 170, 405-408.

Newman, M.G., Hulem, C., Colgate, J., Anselmo, C., 1979. Antibacterial susceptibility of plaque bacteria. J. Dent. Res. 58(7), 1722-1732.

Nisengard, R.J., Kinder Haake, S., Newman, M.G., Miyasaki, K.T., 2006. Microbial interactions with the host in periodontal diseases, in: Newman, M.G., Takei, H.H., Carranza, F.A. (Eds.), Carranza’s Clinical Periodontology. WB Saunders, St Louis, pp. 228-250.

Noguchi, T., Izumizawa, K., Fukuda, M., Kitamura, S., Suzuki, Y., Ikura, H., 1984. New method for local drug delivery using resorbable base material in periodontal therapy. Bull Tokyo Med. Dent. Univ. 31, 145-153.

Nokhodchi, A., Sharabiani, K., Rashidi, M.R., Ghafourian, T., 2007. The effect of terpene concentrations on the skin penetration of diclofenac sodium. Int. J. Pharm. 335(1-2), 97-105.

Novak, M.J., 2006. Classification of diseases and conditions affecting the periodontium, in: Newman, M.G., Takei, H.H., Carranza, F.A. (Eds.), Carranza’s Clinical Periodontology. WB Saunders, St Louis, pp. 100-109.

Noyan, U., Yilmaz, S., Kuru, B., Kadir, T., Acar, O., Büget, E., 1997. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J. Clin. Periodontol. 24, 158-165.

Ntezurubanza, L., Scheffer, J.J.C., Svendsen, A.B., 2008. Composition of the essential oils of Ocimum urticifolium (Lamiaceae) chemotypes grown in Rwanda. Bot. J. Linn. Soc. 96, 97–104.

Nuchuchua, O., Saesoo, S., Sramala, I., Puttipipatkhachorn, S., Soottitantawat, A., Ruktanonchai, U., 2009. Physicochemical investigation and molecular modeling of cyclodextrin complexation mechanism with eugenol. Food Res. Int. 42, 1178–1185.



Ogata, M., Hoshi, M., Urano, S., Endo, T., 2000. Antioxidant activity of eugenol and related monomeric and dimeric compounds. Chem. Pharm. Bull. 48, 1467-1469.

Ohkubo, T., Kitamura, K., 1997. Eugenol activates Ca2+-permeable currents in rat dorsal root ganglion cells. J. Dent. Res. 76, 1737-1744.

Oldroyd, J.G., 1955. The Effect of Interfacial Stabilizing Films on the Elastic and Viscous Properties of Emulsions. Proceedings of the Royal Society of London Series A Mathematical and Physical Sciences 232(1191), 567-577.

Olgun, U., Tunç, K., Özaslan, V., 2011. Preparation of antimicrobial polycaprolactone-silica composite films with nanosilver rods and triclosan using roll-milling method. Polym. Adv. Technol. 22, 232-236.

Olsen, E.A., Dunlap, F.E., Funicella, T., Koperski, J.A., Swinehart, J.M., Tschen, E.H., Trancik, R.J., 2002. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J. Am. Acad. Dermatol. 47(3), 377-385.

Oz, H.S., Puleo, D.A., 2011. Animal models for periodontal disease. J. Biomed. Biotechnol. 2011:754857. doi:10.1155/2011/754857.

Ozcan, G., Taner, I.L., Doğanay, T., Iscanoğlu, M., Taplamacioğlu, B., Gültekin, S.E., Baloş, K., 1994. Use of membranes containing 20% chlorhexidine and 40% doxycycline for treatment of chronic periodontal pockets. J. Nihon Univ. Sch. Dent. 36, 191-198.

Ozmeric, N., 2004. Advances in periodontal disease markers. Clin. Chim. Acta 343, 1-16.

Ozmeric, N., Ozcan, G., Haytac, C.M., Alaaddinoglu, E.E., Sargon, M.F., Senel, S., 2000. Chitosan film enriched with an antioxidant agent, taurine, in fenestration defects. J. Biomed. Mater. Res. 51, 500-503.

Ozturk, A., Ozbek, H., 2005. The anti-inflammatory activity of Eugenia caryophyllata essential oil: an animal model of anti-inflammatory activity. Eur. J. Gen. Med. 2(4), 159-163.

Page, R.C., Schroeder, H.E., 1982. Periodontitis in man and other animals: a comparative review. Korger, New York. pp. 71-106.

Pagonis, T.C., Chen, J., Fontana, C.R., Devalapally, H., Ruggiero, K., Song, X., Foschi, F., Dunham, J., Skobe, Z., Yamazaki, H., Kent, R., Tanner, A.C., Amiji, M.M., Soukos, N.S., 2010. Nanoparticle-based endodontic antimicrobial photodynamic therapy. J. Endod. 36(2), 322-328.

Pal, D., Banerjee, S., Mukherjee, S., Roy, A., Panda, C.K., Das, S., 2010. Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway. J. Dermatol. Sci. 59, 31-39.



Paolantonio, M., D'Angelo, M., Grassi, R.F., Perinetti, G., Piccolomini, R., Pizzo, G., Annunziata, M., D'Archivio, D., D'Ercole, S., Nardi, G., Guida, L., 2008. Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study. J. Periodontol. 79, 271-282.

Park, C.K., Kim, K., Jung, S.J., Kim, M.J., Ahn, D.K., Hong, S.D., Kim, J.S., Oh, S.B., 2009. Molecular mechanism for local anesthetic action of eugenol in the rat trigeminal system. Pain 144, 84-94.

Park, C.K., Li, H.Y., Yeon, K.Y., Jung, S.J., Choi, S.Y., Lee, S.J., Lee, S., Park, K., Kim, J.S., Oh, S.B., 2006. Eugenol inhibits sodium currents in dental afferent neurons. J. Dent. Res. 85, 900-904.

Park, K., Yeo, Y., 2007. Microencapsulation Technology, in: Swarbrick, J. (Ed.), Encyclopedia of Pharmaceutical Technology, third ed., Informa Healthcare, New York, pp. 2315-2325.

Pathak ,T.S., Kim, J.S., Lee, S.J., Baek, D.J., Paeng, K.J., 2008. Preparation of alginic acid and metal alginate from algae and their comparative study. J. Polym. Environ. 16(3), 198–204.

Patil, C.R., Gadekar, A.R., Patel, P.N., Rambhade, A., Surana, S.J., Gaushal, M.H., 2009. Dual effect of Toxicodendron pubescens on carrageenan induced paw edema in rats. Homeopathy 98(2), 88-91.

Pawar, S.K., 2005. Dentifrice herbal tooth powder. WIPO Patent Application WO2005053629.

Pergo, C., Fabre, M., Torres, D., Alonso, M.J., 2006. Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery. Pharmaceutical Research. 23(3), 549-556.

Perugini, P., Genta, I., Conti, B., Modena, T., Pavanetto, F., 2003. Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophilic drug. Int. J. Pharm. 252, 1-9.

Pihlstrom, B.L., Michalowicz, B.S., Johnson, N.W., 2005. Periodontal diseases. Lancet 366, 1809-1820.

Piñón-Segundo, E., Ganem-Quintanar, A., Alonso-Pérez, V., Quintanar-Guerrero, D., 2005. Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int. J. Pharm. 294, 217-232.

Piramal, S.A., Jathar, S.R., Sirwani, R.P., Malhotra, P., 2008. Herbal compositions for the treatment of diseases of the oral cavity. WIPO Patent Application WO2008001325.



Pokharkar, V.B., Shekhawat, P.B., Dhapte, V.V., Mandpe, L.P., 2011. Development and optimization of eugenol loaded nanostructured lipid carriers for periodontal delivery. Int J Pharm Pharm Sci. 3, 138-143.

Polson, A.M., Garrett, S., Stoller, N.H., Bandt, C.L., Hanes, P.J., Killoy, W.J., Southard, G.L., Duke, S.P., Bogle, G.C., Drisko, C.H., Friesen, L.R., 1997. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J. Periodontol. 68, 119-126.

Polson, A.M., Stoller, N.H., Hanes, P.J., Bandt, C.L., Garrett, S., Southard, G.L., 1996. Two multi-center trials assessing the clinical efficacy of 5% sanguinarine in a biodegradable drug delivery system. J. Clin. Periodontol. 23, 782-788.

Pragati, S., Ashok, S., Kuldeep, S., 2009. Recent advances in periodontal drug delivery systems. International Journal of Drug Delivery 1, 1-14.

Prakash, P., Gupta, N., 2005. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J. Physiol. Pharmacol. 49, 125-131.

Prakash, U.R.T., Thiagarajan, P., 2011. Nanoemulsions for drug delivery through different routes. Research in Biotechnology 2(3), 01-13.

Pramod, K., Ansari, S.H., Ali, J., 2009. Herbal remedies for the treatment of periodontal disease - A patent review. Recent Pat. Drug Deliv. Formul. 3, 221-228.

Pramod, K., Ansari, S.H., Ali, J., 2010. Eugenol: A natural compound with versatile pharmacological actions. Nat. Prod. Commun. 5(12), 1999-2006.

Prasad, S., Phromnoi, K., Yadav, V.R., Chaturvedi, M.M., Aggarwal, B.B., 2010. A targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med. 76(11), 1044-1063.

Qiu, D., Kao, P.N., 2003. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 4(1), 1-18.

Quirynen, M., Teughels, W., Kinder Haake, S., Newman, M.G., 2006. Microbiology of periodontal diseases, in: Newman, M.G., Takei, H.H., Carranza, F.A. (Eds.), Carranza’s Clinical Periodontology. WB Saunders, St Louis, pp. 134-169.

Rachelson, A., Zilberman, M., 2009. Highly porous nano and microstructured films loaded with bioactive agents for biomedical applications. Structure release profile effects. Adv. Eng. Mater. 11(8), B122-B128.

Rafael, M., Barros, L., Carvalho, A.M., Ferreira, I.C.F.R., 2011. Topical anti-inflammatory plant species: Bioactivity of Bryonia dioica, Tamus communis and Lonicera periclymenum fruits. Ind. Crop. Prod. 34, 1447-1454.



Rams, T.E., Slots, J., 1996. Local delivery of antimicrobial agents in the periodontal pocket. Periodontol. 2000 10, 139-159.

Rapp, C., 2007. Clove oil as effective as topical anesthetic. HerbalGram 74, 26.

Ratnam, D.V., Ankola, D.D., Bhardwaj, V., Sahana, D.K., Kumar, M.N.V.R., 2006. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Release 113, 189–207.

Raybachuk, A.V., Chekman, I.S., Nebesna, T.Y., 2009. Nanotechnology and nanoparticles in dentistry. Pharmacology and Pharmaceutics (1), 18-21.

Reddy, M. S., Reddy, D. R. K., Prasad, N. A. V., 2000. Herbal and pharmaceutical drugs enhanced with probiotics. WIPO Patent Application WO00029007.

Reddy, P.D., Swarnalatha, D., 2010. Recent Advances in Novel Drug Delivery Systems. Int. J. PharmTech Res. 2(3), 2025-2027.

Reis, C.P., Neufeld, R.J., Ribeiro, A.J., Veiga, F., 2006. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine 2, 8– 21.

Resende, K.X., Corrêa, M.A., de Oliveira, A.G., Scarpa, M.V., 2008. Effect of cosurfactant on the supramolecular structure and physicochemical properties of non-ionic biocompatible microemulsions. Braz. J. Pharm. Sci. 44(1), 35-42.

Reuter, B.K., Cirino, G., Wallace, J.L., 1994. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci. 55(1), PL1-PL8.

Right, D.A., Payne, J.P., 1962. A clinical Study of Intravenous Anaesthesia with a Eugenol Derivative, G.29.505. Br. J. Anaesth. 34, 379-385.

Rivers, J.K., Arlette, J., Shear, N., Guenther, L., Carey, W., Poulin, Y., 2002. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br. J. Dermatol. 146(1), 94-100.

Robinson, A.M., Creeth, J.E., Jones, M.N., 1998. The specificity and affinity of immunoliposome targeting to oral bacteria. Biochim. Biophys. Acta 1369(2), 278-286.

Rodrigues, T.G., Fernandes, A., Sousa, J.P.B., Bastos, J.K., Sforcin, J.M., 2009. In vitro and in vivo effects of clove on pro-inflammatory cytokines production by macrophages. Nat. Prod. Res. 23, 319-326.

Romanowski, R.. Emily, P., Alkemade, S., 2005. Method and compositions for oral hygiene. US Patent Application US20050158252A1.



Romoscanu, A.I., Sayir, M.B., Hausler, K., Burbidge, A.S., 2003. High frequency parallel plate probe for the measurement of the complex viscosity of liquids, Rheol. Acta. 42, 462–476.

Rompelberg, C., Vogels, J., de Vogel, N., Rozier, G.B., Stenhuis, W.H., Bogaards, J., Verhagen, H., 1996. Effect of short-term dietary administration of eugenol in humans. Hum. Exp. Toxicol. 15, 129-135.

Rowe, R.C., Sheskey, P.J., Owen, S.C., 2004. Handbook of Pharmaceutical Excipients, fifth ed. Pharmaceutical Press, London.

Russell, J.L., Rideal, E.K., 1936. Studies in thixotropic gelation. I. The mechanism of thixotropic gelation. Proceedings of the Royal Society of London Series A Mathematical and Physical Sciences 154(883), 540-549.

Sabaa, M.W., Mohamed, R.R., 2007. Organic thermal stabilizers for rigid poly(vinyl chloride).Part XIII: Eugenol (4-allyl-2-methoxy-phenol). Polym. Degrad. Stabil. 92, 587-595.

Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. 2011. Development and in vitro evaluation of thiolated chitosan--Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system. Int J Biol Macromol. 48(3), 403-407.

Sahoo, S., Sasmal, A., Sahoo, D., Nayak, P., 2010. Synthesis and characterization of chitosan- polycaprolactone blended with organoclay for control release of doxycycline. J. Appl. Polym. Sci. 118, 3167–3175.

Sahoo, S.K., Parveen, S., Panda, J.J., 2007. The present and future of nanotechnology in human health care. Nanomedicine, 3, 20-31.

Said, M.M., 2011. The protective effect of eugenol against gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Fundam. Clin. Pharmacol. 25(6), 708-716.

Sakugawa, K., Ikeda, A., Takemura, A., Ono, H., 2004. Simplified method for estimation of composition of alginates by FTIR. J. Appl. Polym. Sci. 93, 1372–1377.

Salah, A.M., Gathumbi, J., Vierling, W., 2002. Inhibition of intestinal motility by methanol extracts of Hibiscus sabdariffa L. Phytother. Res. 16, 283-285.

Santini Jr, J.T., Richards, A.C., Scheidt, R., Cima, M.J., Langer R., 2000. Microchips as Controlled Drug-Delivery Devices. Angew. Chem. Int. Ed. 39, 2396-2407.

Santos, A.L., Chierice, G.O., Alexander, K.S., Riga, A., Matthews, E., 2009. Characterization of the raw essential oil eugenol extracted from Syzygium aromaticum L. J. Therm. Anal. Calorim. 96, 821–825.



Saravana, K.R., Vijayalakshmi, R., 2006. Nanotechnology in Dentistry. Ind. J. Dent. Res. 17(2), 62-65.

Sarigüllü Ozgüney, I., Yeşim Karasulu, H., Kantarci, G., Sözer, S., Güneri, T., Ertan, G.,2006. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech. 7(4), 88E1-88E7.

Satishkumar, R., Vertegel, A., 2008. Charge-directed targeting of antimicrobial protein-nanoparticle conjugates. Biotechnol. Bioeng. 100, 403-412.

Scherlund, M., Malmsten, M., Holmqvist, P., Brodin, A., 2000. Thermosetting microemulsions and mixed micellar solutions as drug delivery systems for periodontal anesthesia. Int. J. Pharm. 194, 103-116.

Schroeder, H.E., De Boever, J., 1970. The Structure of Microbial Dental Plaque, in: McHugh, W.D. (Ed.), Dental Plaque. E. & S. Livingston Ltd, Edinburgh, pp. 49-75.

Schwach-Abdellaoui, K., Vivien-Castoni, N., Gurny, R., 2000. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur. J. Pharm. Biopharm. 50, 83-99.

Sensch, O., Vierling, W., Brandt, W., Reiter, M., 2000. Effects of inhibition of calcium and potassium currents in Guinea-pig cardiac contraction: comparison of beta caryophyllene oxide, eugenol, and nifedipine. Br. J. Pharmacol. 131, 1089-1096.

Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F.J., Khar, R.K., Ali, M., 2007. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66(2), 227-243.

Shah, A., Garg, A., Sairam, K., Singh, S., 2010. Pharmacological evaluation of eugenol loaded solid lipid nanoparticles in irritable bowel syndrome. Available form: www.scientificipca.org/paper/2009/09/25/200909251910570A.doc [Accessed 10 March 2011].

Shan, X., Chen, L., Yuan, Y., Liu, C., Zhang, X., Sheng, Y., Xu, F., 2010. Quantitative analysis of hemoglobin content in polymeric nanoparticles as blood substitutes using Fourier transform infrared spectroscopy. J. Mater. Sci. Mater. Med. 21(1), 241-249.

Shanmuganathan, S., Shanumugasundaram, N., Adhirajan, N., Lakshmi, T.S.R., Babu, M., 2008. Preparation and characterization of chitosan microspheres for doxycycline delivery. Carbohyd. Polym. 73, 201-211.

Sharma, G., Anabousi, S., Ehrhardt, C., Ravi Kumar, M.N., 2006. Liposomes as targeted drug delivery systems in the treatment of breast cancer. J. Drug Target. 14, 301–310.

Sharma, J.N., Srivastava, K.C., Gan, E.K., 1994. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 49(5), 314-318.



Shefer, A., Shefer, S.D., 2003. Biodegradable bioadhesive controlled release system of nanoparticles for oral care products. US Patent 6565873.

Shen, Q., Li, W., Li, W., 2007. The effect of clove oil on the transdermal delivery of Ibuprofen in the rabbit by in vitro and in vivo methods. Drug Dev. Ind. Pharm. 33, 1369-1374.

Shi, W., Chen, L., Park, N., Anderson, M., 2003. Herbs and herbal combinations useful for the treatment of microbial infections. WIPO Patent Application WO03099110.

Shokeen, P., Bala, M., Singh, M., Tandon, V., 2008. In vitro activity of eugenol, an active component from Ocimum sanctum, against multiresistant and susceptible strains of Neisseria gonorrhoeae. Int. J. Antimicrob. Agents 32, 174-179.

Shu-Ya, J., 2010. Encapsulation of active substance in nanocapsules by emulsion-diffusion method. Available from: http://140.121.155.217/seminar/19932033-1.pdf [Accessed 12 February 2011].

Singka, G.S., Samah, N.A., Zulfakar, M.H., Yurdasiper, A., Heard, C.M., 2010. Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. Eur. J. Pharm. Biopharm. 76(2), 275-281.

Sinha, V.R., Bansal, K., Kaushik, R., Kumria, R., Trehan, A., 2004. Poly-ε-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278, 1-23.

Slots, J., Rams, T.E., 1990. Antibiotics in periodontal therapy: advantages and disadvantages. J. Clin. Periodontol. 17, 479-493

Snoeck, R., Bossens, M., Parent, D., Delaere, B., Degreef, H., Van Ranst, M., Noël, J.C., Wulfsohn, M.S., Rooney, J.F., Jaffe, H.S., De Clercq, E., 2001. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis. 33(5), 597-602.

Soares, J.P., Santos, J.E., Chierice, G.O., Cavalheiro, E.T.G., 2004. Thermal behavior of alginic acid and its sodium salt. Ecletica Quimica 29(2), 53–56.

Soliman, K.M., Badeaa, R.I., 2002. Effect of oil extracted from some medicinal plants on different mycotoxigenic fungi. Food Chem. Toxicl. 40(11), 1669-1675.

Soskolne, A., Golomb, G., Friedman, M., Sela, M.N., 1983. New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy. J. Periodontal Res. 18, 330-336.

Southard, G.L., Godowski, K.C., 1998. Subgingival controlled release of antimicrobial agents in the treatment of periodontal disease. Int. J. Antimicrob. Agents 9, 239-253.



Souza, D.M., Ricardo, L.H., Prado, M.A., Prado, F.A., Rocha, R.F., 2006. The effect of alcohol consumption on periodontal bone support in experimental periodontitis in rats. J. Appl. Oral Sci. 14(6), 443-447.

Steffe, J.F, 1996. Rheological methods in food process engineering, second ed. Freeman Press, Michigan.

Steinberg, D., Friedman, M., 1998. Sustained release drug delivery devices for treatment of dental diseases, in: Tyle, P. (Ed.), Drug delivery devices: Fundamentals and applications. Marcel Dekker, New York, pp. 491-515.

Steinberg, D., Friedman, M., Soskolne, A., Sela, M.N., 1990. A new degradable controlled release device for treatment of periodontal disease: in vitro release study. J. Periodontol. 61, 393-398.

Struillou, X., Boutigny, H., Soueidan, A., Layrolle, P., 2010. Experimental animal models in periodontology: a review. The Open Dentistry Journal 29, 37–47.

Suh, Y.T., Kim, C.K., Yang, S.J., Sim, Y.C., Park, S.N., Park, W.J., Lee, H.J., Jeon, K.B. 1993. Compositions containing herbal extracts - of myrrh, mulberry bark, cimicifuga and/or green tea, esp. for oral hygiene. DE4221103A1.

Svenson, S., Tomalia, D.A., 2006. Dendrimers as Nanoparticulate Drug Carriers, in: Torchilin, V.P. (Ed.), Nanoparticulates as Drug Carriers. Imperial college press, London, pp. 277-306.

Taira, J., Ikemoto, T., Yoneya, T., Hagi, A., Murakami, A., Makino, K., 1992. Essential oil phenyl propanoids. Useful as OH scavengers? Free Radic. Res. 16, 197-204.

Tajuddin, Ahmad, S., Latif, A., Qasmi, I.A., 2003. Aphrodisiac activity of 50% ethanolic extracts of Myristica fragrans Houtt. (nutmeg) and Syzygium aromaticum (L) Merr. & Perry. (clove) in male mice: a comparative study. BMC Complement. Altern. Med. 20: 3-6.

Tan, P.V., Nyasse, B., Dimo, T., Mezui, C., 2002. Gastric cytoprotective anti-ulcer effects of the leaf methanol extract of Ocimum suave (Lamiaceae) in rats. J. Ethnopharmacol. 82, 69-74.

Taner, I.L., Ozcan, G., Doğanay, T., Iscanolu, M., Taplamacioğlu, B., Gültekin, S.E., Baloş, K., 1994. Comparison of the antibacterial effects on subgingival microflora of two different resorbable base materials containing doxycycline. J. Nihon Univ. Sch. Dent. 36, 183-190.

Tao, X., Lipsky, P.E., 2000. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum. Dis. Clin. North. Am. 26(1), 29-50.



Terreno, E., Delli Castelli, D., Cabella, C., Dastru, W., Sanino, A., Stancanello, J., Tei, L., Aime, S., 2008. Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications. Chem Biodivers. 5,1901-1912.

Thame, N., 1989. Use of periwinkle in oral hygiene. WIPO Patent Application US4853213.

Thame, N., 1990. Use of periwinkle in oral hygiene. WIPO Patent Application US4952392.

Thompson, D., Eling, T., 1989. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates. Mol. Pharmacol. 36, 809-817.

Tiu, C., Guo, J., Uhlherr, P.H.T., 2006. Yielding Behaviour of Viscoplastic Materials, J. Ind. Eng. Chem. 12, 653-662.

Tixier, N., Guibau, G., Baudu, M., 2003. Towards a rheological parameter for activated sludge bulking characterization. Enzym. Microb. Tech. 33, 292–298.

Tiyaboonchai, W., Tungpradit, W., Plianbangchang, P., 2007. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337, 299-306.

Tolo, K.J., 1971. A study of permebility of gingival pocket epithelium to albumin in guinea pigs and Norwegian pigs. Arch Oral Biol. 16, 881–888.

Tonetti, M., Cugini, M.A., Goodson, J.M., 1990. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibres. J. Periodontal Res. 25, 243-249.

Torchilin, V.P., 2001. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73, 137-172.

Tragoolpua, Y., Jatisatienr, A., 2007. Anti-herpes simplex virus activities of Eugenia caryophyllus (Spreng.) Bullock & S. G. Harrison and essential oil, eugenol. Phytother. Res. 21, 1153–1158.

Uhumwangho, M.U., Okor, R.S., 2005. Effect of humidity on the disintegrant property of α-cellulose, Part II: A technical note. AAPS PharmSciTech. 6(1), E31–E34.

Ure, D., Harris, J., 2003. Nanotechnology in dentistry: reduction to practice. Dent. Update, 30, 10-15.

USP 29, 2006, The United States Pharmacopoeial convention Inc., Rockville, USA.

Vandekerckhove, B.N., Quirynen, M., van Steenberghe, D., 1997. The use of tetracycline-containing controlled release fibers in the treatment of refractory periodontitis. J. Periodontol. 68(4), 353-361.



Vasavada, R.C., Junnarkar, G.H., 1997. Release of metronidazole from poly(orthoester) matrices. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24, 499-500.

Vidhya, N., Devaraj, S.N., 1999. Antioxidant effect of eugenol in rat intestine. Indian J. Exp. Biol. 37, 1192-1195.

Vladimir, T., 2006. Nanocarriers for Drug Delivery: Needs and Requirements, in: Vladimir, P.T. (Ed.), Nanoparticulates as Drug Carriers. Imperial college press, London, pp.1 - 8.

Vyas, S.P., Khar, R.K., 2002. Targeted and controlled drug delivery: Novel carrier systems, first ed. CBS Publishers and Distributors, New Delhi.

Vyas, S.P., Sihorkar, V., Dubey, P.K., 2001. Preparation, characterization and in vitro antimicrobial activity of metronidazole bearing lectinized liposomes for intraperiodontal pocket delivery. Pharmazie 56(7), 554–560.

Wade, W.G., Moran, J., Morgan, J.R., Newcombe, R., Addy, M., 1992. The effects of antimicrobial acrylic strips on the subgingival microflora in chronic periodontitis. J. Clin. Periodontol. 19, 127-134.

Wang, J.P., Zhou, Y.M., Ye, Y.J., Shang, X.M., Cai, Y.L., Xiong, C.M., Wu, Y.X., Xu, H.X., 2011. Topical anti-inflammatory and analgesic activity of kirenol isolated from Siegesbeckia orientalis. J. Ethnopharmacol. 137, 1089-1094.

Wang, J.X., Zhang, Z.B., Le, Y., Zhao, H., Chen, J.F., 2011. A novel strategy to produce highly stable and transparent aqueous 'nanosolutions' of water-insoluble drug molecules. Nanotechnology 22(30), 1-7.

Wang, L.C., Chen, X.G., Zhong, D.Y., Xu, Q.C., 2007. Study on poly (vinyl alcohol)/carboxymethyl-chitosan blend film as local drug delivery system. J. Mater. Sci. Mater. Med. 18, 1125-1133.

Wang, L.H., Liu, H.J., 2010. Determination of fragrance allergens in essential oils and evaluation of their in vitro permeation from essential oil formulations through cultured skin. J. Bioequiv. Availab. 2, 072-076.

Wang, S., Guo, S., 2008. Formation mechanism and release behavior of poly(ε -caprolactone) microspheres containing disodium norcantharidate. Eur. J. Pharm. Biopharm. 69(3), 1176-1181.

Wang, S., Guo, S., Cheng, L., 2008. Disodium norcantharidate loaded poly(ε-caprolactone) microspheres I. Preparation and evaluation. Int. J. Pharm. 350(1-2), 130-137

Weidner, J., 2001. A drug delivery system for the treatment of periodontitis. Drug. Discov. Today 6(16), 862–863.



Wells, J., 2002. Pharmaceutical preformulation: the physicochemical properties of drug substances, in: Aulton, M.E., (Ed.), Pharmaceutics The science of dosage form design. second ed. Churchill Livingstone, London, pp. 114-138.

Wie, M.B., Won, M.H., Lee, K.H., Shin, J.H., Lee, J.C., Suh, H.W., Song, D.K., Kim, Y.H., 1997. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci. Lett. 225, 93-96.

Wiggs, R.B., Lobprise, H.B., 1997. Periodontology, in: Wiggs, R.B., Lobprise, H.B.(Eds.), Veterinary dentistry principles and practice. Lippincott-Raven, Philadelphia, pp. 186-231.

Wikipedia, 2011a. Zinc oxide eugenol. Available from: http://en.wikipedia.org/wiki/Zinc_oxide_eugenol [Accessed 20 August 2011].

Wikipedia, 2011b. Inflammation, Available from: http://en.wikipedia.org/wiki/Inflammation [Accessed 21 August 2011].

Wikipedia, 2011c. Ethanol. Available from: http://en.wikipedia.org/wiki/Ethanol [Accessed 20 August 2011].

Wilking, J.N., Mason, T.G., 2007. Irreversible shear-induced vitrification of droplets into elastic nanoemulsions by extreme rupturing. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 75, 041407.

Williams III, R.O., Vaughn, J.M., 2007. Nanoparticle engineering, in: Swarbrick, J. (Ed.), Encyclopedia of pharmaceutical technology, third ed. Informa Healthcare, New York, pp. 2384–2398.

Wu, C.S., 2003. Physical properties and biodegradability of maleated-polycaprolactone/starch composite. Polym. Degrad. Stabil. 80, 127–134.

Xie, R., Kuijpers-Jagtman, A.M., Maltha, J.C., 2011. Inflammatory responses in two commonly used rat models for experimental tooth movement: comparison with ligature-induced periodontitis. Arch. Oral Biol. 56(2), 159-167.

Xu, H., Delling, M., Jun, J.C., Clapham, D.E., 2006. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci. 9, 628-635.

Yan X., Wei, W., 2006. A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats. Arch. Oral Biol. 51(9): 794-803.

Yan, X., Wei, W., 2006. A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats. Arch. Oral Biol. 51(9), 794-803.



Yang, B.H., Piao, Z.G., Kim, Y.B., Lee, C.H., Lee, J.K., Park, K., Kim, J.S., Oh, S.B., 2003. Activation of vanilloid receptor 1 (VR1) by eugenol. J. Dent. Res. 82, 781-785.

Yang, Y., Song, L.X., 2005. Study on the inclusion compounds of eugenol with α-, β-, γ- and heptakis (2,6-di-O-methyl)-β-cyclodextrins. J. Inclusion Phenom. Macrocyclic Chem. 53, 27–33.

Yogalakshmi, B., Viswanathan, P., Anuradha, C.V., 2010. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 268, 204-212.

Yu ,T., Ahn, H.M., Shen, T., Yoon, K., Jang, H.J., Lee, Y.J., Yang, H.M., Kim, J.H., Kim, C., Han, M.H., Cha, S.H., Kim, T.W., Kim, S.Y., Lee, J., Cho, J.Y., 2011. Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans. J. Ethnopharmacol. 137, 1197-1206.

Yuan, D.F., Yi, Y.M., 2003. Advance of the research on liver-targeted nanoparticles. Her. Med. 22, 113–114.

Yue, I.C, Poff, J., Cortés, M.E., Sinisterra, R.D., Faris, C.B., Hildgen, P., Langer, R., Shastri, V.P., 2004. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease. Biomaterials 25, 3743-3750.

Zelger, K.R.D., Zelger, J.L., Carlini, E.A., 1983. New anticonvulsants derived from 4-allyl-2-methoxyphenol (eugenol): comparison with common antiepileptics in mice. Pharmacology 27, 40-49.

Zhao, K., Singh, J., 1998. Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone. J. Control. Release 55, 253-260.

Zhao, K., Singh, J., 1998. Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone. J. Control. Release 55(2-3), 253-260.

Zheng, G.Q., Kenney, P.M., Lam, L.K.T., 1992. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J. Nat. Prod. 55, 999–1003.

Zhinan, M., Huabing, C., Ting, W., Yajiang, Y., Xiangliang, Y., 2003. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56, 189–196.

Zhu, J., 2006. Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof. European Patent Application EP1504763A4.

Zili, Z., Sfar, S., Fessi, H., 2005. Preparation and characterization of poly-ε-caprolactone nanoparticles containing griseofulvin. Int. J. Pharm. 294, 261–267.

Documents

CHAPTER 7 REFERENCES 247shodhganga.inflibnet.ac.in/bitstream/10603/12396/10/13... · 2015. 12. 4. · periodontal diseases. Autoimmun Rev. 10(7), ... herbal formulation for preventing